Funding for this research was provided by:
kwf kankerbestrijding (10606/2016-2)
Received: 1 July 2021
Accepted: 11 September 2021
First Online: 26 September 2021
: The Medical Ethics Committee of the Netherlands Cancer Institute (CCMO trial registration NL71902.031.20) approved the study protocol. The study was conducted in accordance with the Declaration of HELSINKI. Written and oral informed consent was obtained from all patients prior to study entry.
: Not applicable.
: The authors have no conflicts of interest to declare that are relevant to the content of this article.